Search results
Broadcom surges to a record after earnings. 3 reasons why the stock can go even higher
CNBC· 1 day agoBroadcom surged more than 12% to a record high Thursday following an excellent fiscal second-quarter...
IBD Sector Leaders: Top Picks To Watch Include Nvidia Stock, Ozempic Maker Novo Nordisk
Investor's Business Daily· 11 hours agoThe stock initially moved above this level on Wednesday. The 400 level also coincides with a three...
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity...
Motley Fool via Yahoo Finance· 21 hours agoThe Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Wegovy's...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: NVIDIA, Alphabet,...
Zacks via Yahoo Finance· 21 hours agoBuy) or 2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. NVIDIA Corp....
Nvidia stock forecast: After rising more than 200% in a year the chipmaker could be fabulously...
Fortune via Yahoo Finance· 2 days agoWe’ll assume that almost all of the future increases will come in capital gains. Despite the big...
Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
Investor's Business Daily· 12 hours agoNeurocrine Biosciences continues to put up really healthy numbers, with an ostensible 335% profit...
Is Eli Lilly Stock A Buy After FDA Advisors Back Its Alzheimer's Drug?
Investor's Business Daily· 4 days agoFurther, Lilly entered into a collaboration with Verve Therapeutics to test three potential...
Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
Zacks via Yahoo Finance· 14 hours agoThe FDA approves Bristol Myers' (BMY) cancer drug Augtyro for the treatment of adult and pediatric...
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
Zacks via Yahoo Finance· 2 days agoFollowing the label expansion, AstraZeneca's (AZN) Farxiga is now approved to improve glycemic...
AstraZeneca's (AZN) Tagrisso sNDA Gets FDA's Priority Tag
Zacks via Yahoo Finance· 5 days agoThe FDA grants priority review to AstraZeneca's (AZN) Tagrisso for treating patients with...